StonvexLoading…
StonvexStonvexStonvexCore line items from HLIO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q2 2026 2026-04-04 | Annual 2026 2026-01-03 | Q3 2025 2025-09-27 | Q2 2025 2025-06-28 |
|---|---|---|---|---|
Revenue | $228.40M | $839.00M | $628.20M | $408.00M |
Operating Income | $29.90M | $66.00M | $40.30M | $39.00M |
Net Income | $19.70M | $48.40M | $28.90M | $18.60M |
EPS (Diluted) | $0.59 | $1.45 | $0.87 | $0.56 |
Total Assets | $1.51B | $1.51B | $1.56B | $1.58B |
Total Liabilities | $575.30M | $583.00M | $637.90M | $670.00M |
Cash & Equivalents | $64.20M | $73.00M | $54.90M | $53.00M |
Free Cash Flow OCF − CapEx | $17.20M | $103.60M | $63.10M | $44.50M |
Shares Outstanding | 33.10M | 33.10M | 33.10M | 33.30M |